Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer.

about

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-2.

P2860

Q48337589-753DD29A-DD09-4F8B-BC9B-1E55D3639FF8

P2860

Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer.

Item

http://www.wikidata.org/entity/Q47142699

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Metabolomics reveals novel blo ...... notype of human breast cancer.

@en

Metabolomics reveals novel blo ...... notype of human breast cancer.

@nl

type

Item

label

Metabolomics reveals novel blo ...... notype of human breast cancer.

@en

Metabolomics reveals novel blo ...... notype of human breast cancer.

@nl

prefLabel

Metabolomics reveals novel blo ...... notype of human breast cancer.

@en

Metabolomics reveals novel blo ...... notype of human breast cancer.

@nl

P1476

Metabolomics reveals novel blo ...... notype of human breast cancer.

@en

P2093

Ana R Gomes

http://www.w3.org/2001/XMLSchema#string

Bàrbara Roig

http://www.w3.org/2001/XMLSchema#string

Joan Borràs

http://www.w3.org/2001/XMLSchema#string

Sandra Guaita-Esteruelas

http://www.w3.org/2001/XMLSchema#string

Sara Samino

http://www.w3.org/2001/XMLSchema#string

P2860

A Guideline to Univariate Statistical Analysis for LC/MS-Based Untargeted Metabolomics-Derived Data

Evaluation of the methods to identify patients who may benefit from PARP inhibitor use

DNA N(6)-methyladenine: a new epigenetic mark in eukaryotes?

Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Proposed minimum reporting standards for chemical analysis

Molecular portraits of human breast tumours

XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Merging transcriptomics and metabolomics--advances in breast cancer profiling.

P2888

s41598-017-17897-8

P304

17831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-17897-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Oscar Yanes

Xavier Correig

Eric W-F Lam

Marta Rodríguez-Balada

J Gumà

P577

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29259228

http://www.w3.org/2001/XMLSchema#string

P932

5736621

http://www.w3.org/2001/XMLSchema#string

Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer.

about

P2860

P2860

Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932